SDC2 expression is upregulated in breast, colon, and pancreatic cancers, and melanomas, whereas high levels of SDC2 in neuroendocrine tumors correlate with a better survival of patients [112,113]. The gene discussed is SDC2; the disease is pancreatic neoplasm.